Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUCOCOVID: Early corticosteroids in hospitalized COVID-19 patients
2020-001934-37Phase 4Active
- Sponsor
- IDIVAL
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Methylprednisolone arm with Standard of care arm (2 arms). Primary endpoint: Primary composite endpoint. Started May 2020; status: active.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001934-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001934-37.